<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30158824</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1178-2234</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>12</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Breast cancer : basic and clinical research</Title>                <ISOAbbreviation>Breast Cancer (Auckl)</ISOAbbreviation>            </Journal>            <ArticleTitle>Formin Proteins FHOD1 and INF2 in Triple-Negative Breast Cancer: Association With Basal Markers and Functional Activities.</ArticleTitle>            <Pagination>                <MedlinePgn>1178223418792247</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1177/1178223418792247</ELocationID>            <Abstract>                <AbstractText>Basal-like breast cancer is an aggressive form of breast cancer with limited treatment options. The subgroup can be identified immunohistochemically, by lack of hormone receptor expression combined with expression of basal markers such as CK5/6 and/or epidermal growth factor receptor (EGFR). In vitro, several regulators of the actin cytoskeleton are essential for efficient invasion of basal-like breast cancer cell lines. Whether these proteins are expressed in vivo determines the applicability of these findings in clinical settings. The actin-regulating formin protein FHOD1 participates in invasion of the triple-negative breast cancer cell line MDA-MB-231. Here, we measure the expression of FHOD1 protein in clinical triple-negative breast cancers by using immunohistochemistry and further characterize the expression of another formin protein, INF2. We report that basal-like breast cancers frequently overexpress formin proteins FHOD1 and INF2. In cell studies using basal-like breast cancer cell lines, we show that knockdown of FHOD1 or INF2 interferes with very similar processes: maintenance of cell shape, migration, invasion, and proliferation. Inhibition of EGFR, PI3K, or mitogen-activated protein kinase activity does not alter the expression of FHOD1 and INF2 in these cell lines. We conclude that the experimental studies on these formins have implications in the clinical behavior of basal-like breast cancer.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Heuser</LastName>                    <ForeName>Vanina D</ForeName>                    <Initials>VD</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Biomedicine, University of Turku, Turku, Finland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Turku University Hospital, Turku, Finland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>MediCity Research Laboratory, University of Turku, Turku, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mansuri</LastName>                    <ForeName>Naziha</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Biomedicine, University of Turku, Turku, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mogg</LastName>                    <ForeName>Jasper</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kurki</LastName>                    <ForeName>Samu</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Auria Biobank, Turku University Hospital and University of Turku, Turku, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Repo</LastName>                    <ForeName>Heli</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Biomedicine, University of Turku, Turku, Finland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Turku University Hospital, Turku, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kronqvist</LastName>                    <ForeName>Pauliina</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Biomedicine, University of Turku, Turku, Finland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Turku University Hospital, Turku, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Carp√©n</LastName>                    <ForeName>Olli</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Biomedicine, University of Turku, Turku, Finland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gardberg</LastName>                    <ForeName>Maria</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Biomedicine, University of Turku, Turku, Finland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Turku University Hospital, Turku, Finland.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>24</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Breast Cancer (Auckl)</MedlineTA>            <NlmUniqueID>101474356</NlmUniqueID>            <ISSNLinking>1178-2234</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 2010 Jan;42(1):72-6</RefSource>                <PMID Version="1">20023659</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Histochem Cytochem. 2014 Apr 3;62(6):460-470</RefSource>                <PMID Version="1">24700756</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Dev Cell. 2013 Dec 9;27(5):545-59</RefSource>                <PMID Version="1">24331927</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Cancer Res. 2016 Aug 01;6(8):1609-23</RefSource>                <PMID Version="1">27648353</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2013 Sep 13;288(37):26847-55</RefSource>                <PMID Version="1">23921379</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Pathol. 2013 Oct;183(4):1064-1074</RefSource>                <PMID Version="1">23920327</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2016 Jan 4;44(D1):D746-52</RefSource>                <PMID Version="1">26481351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2013 Jan 25;339(6118):464-7</RefSource>                <PMID Version="1">23349293</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mod Pathol. 2006 Feb;19(2):264-71</RefSource>                <PMID Version="1">16341146</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Sci. 2013 Apr 15;126(Pt 8):1891-901</RefSource>                <PMID Version="1">23444374</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2004 Aug 15;10(16):5367-74</RefSource>                <PMID Version="1">15328174</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Sci. 2016 Jan 15;129(2):298-313</RefSource>                <PMID Version="1">26621033</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cell Biol. 2014 May-Jun;93(5-6):205-11</RefSource>                <PMID Version="1">24342720</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2009 Aug;20(8):1319-29</RefSource>                <PMID Version="1">19535820</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2000 Aug 17;406(6797):747-52</RefSource>                <PMID Version="1">10963602</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncologist. 2013;18(2):123-33</RefSource>                <PMID Version="1">23404817</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Mol Cell Biol. 2010 May;11(5):353-65</RefSource>                <PMID Version="1">20414257</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Sci. 2009 May 1;122(Pt 9):1430-40</RefSource>                <PMID Version="1">19366733</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2009 Jul 03;4(7):e6146</RefSource>                <PMID Version="1">19582160</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>EMBO J. 2008 Feb 20;27(4):618-28</RefSource>                <PMID Version="1">18239683</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2011 Aug;22(8):1736-47</RefSource>                <PMID Version="1">21709140</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 2012 Feb;32(3):633-51</RefSource>                <PMID Version="1">22144583</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cytoskeleton (Hoboken). 2017 Nov;74(11):405-419</RefSource>                <PMID Version="1">28921928</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Biol Cell. 2011 Dec;22(24):4822-33</RefSource>                <PMID Version="1">21998196</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Cell Res. 2005 May 15;306(1):192-202</RefSource>                <PMID Version="1">15878344</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Sci. 2014 Apr 1;127(Pt 7):1379-93</RefSource>                <PMID Version="1">24481812</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Mol Cell Biol. 2010 Jan;11(1):62-74</RefSource>                <PMID Version="1">19997130</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013 Sep 26;8(9):e74923</RefSource>                <PMID Version="1">24086398</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS Genet. 2017 Apr 27;13(4):e1006748</RefSource>                <PMID Version="1">28448495</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Cell Res. 2017 Jan 1;350(1):267-278</RefSource>                <PMID Version="1">27919746</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2015 Nov;24 Suppl 2:S26-35</RefSource>                <PMID Version="1">26253814</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Mar 28;483(7391):603-7</RefSource>                <PMID Version="1">22460905</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biol. 2018 Mar 5;217(3):929-944</RefSource>                <PMID Version="1">29321169</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74</RefSource>                <PMID Version="1">11553815</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2011 Dec 22;365(25):2377-88</RefSource>                <PMID Version="1">22187985</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biol. 2012 Sep 17;198(6):1025-37</RefSource>                <PMID Version="1">22986496</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2008 Mar 1;14(5):1368-76</RefSource>                <PMID Version="1">18316557</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">BT-549</Keyword>            <Keyword MajorTopicYN="N">FHOD1</Keyword>            <Keyword MajorTopicYN="N">Formin</Keyword>            <Keyword MajorTopicYN="N">INF2</Keyword>            <Keyword MajorTopicYN="N">MDA-MB-231</Keyword>            <Keyword MajorTopicYN="N">actin</Keyword>            <Keyword MajorTopicYN="N">basal-like breast cancer</Keyword>            <Keyword MajorTopicYN="N">cytoskeleton</Keyword>            <Keyword MajorTopicYN="N">triple-negative breast cancer</Keyword>        </KeywordList>        <CoiStatement>Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>04</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30158824</ArticleId>            <ArticleId IdType="doi">10.1177/1178223418792247</ArticleId>            <ArticleId IdType="pii">10.1177_1178223418792247</ArticleId>            <ArticleId IdType="pmc">PMC6109849</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>